Gros B, Galán A, González-Parra E, Herrero JA, Oyagüez I, Keith M, Casado MA
Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride in the treatment if hyperphosphatemia in end-stage renal disease patients in Spainy
50th Congress of European Renal Association-European Dyalisis and Transplant Association (ERA-EDTA). Estambul, Turquía. 18-21 may 2013
Fernández-Rivera C, Torre-Cisneros J, Guirado-Perich L, Oyagüez I, Ruiz-Beato E
Cost-effectiveness modelto evaluate 200-day vs 100-day treatment with valganciclovir prophylaxis to reduce cytomegalovirus disease in high-risk (D+/R-) kidney transplant recipient in Spain
14th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Madrid, Spain 5-8 nov 2011
Fernández-Rivera C, Torre-Cisneros J, Guirado-Perich L, Sabater-Cabrera E, Ruiz-Beato E
Análisis coste-utilidad de valganciclovir durante 200 días frente a 100 días como tratamiento preventivo de la enfermedad de citomegalovirus en receptores de trasplante renal de alto riesgo (D+/R-)
XLI Congreso Nacional de la Sociedad Española de Nefrología. Sevilla, España. 15-18 oct 2011. Comunicación oral
Guirado-Perich L, Torre-Cisneros J, Fernández-Rivera C, Oyagüez I, Ruiz-Beato E
Cost-effectiveness model to evaluate 200-day vs 100-day treatment with valganciclovir prophylaxis to reduce Cytomegalovirus disease in high-risk (D+/R-) kidney transplant recipient in Spain
15th Congress of European Society for Organ Transplantation. Glasgow, United Kingdom. 4-7 sep 2011. Comunicación oral
Fernández-Rivera C, Guirado-Perich L, Torre-Cisneros J, Sabater-Cabrera E, Ruiz-Beato E